Compare Mueller Industries Inc. Common Stock (MLI) vs Spyre Therapeutics Inc. Common Stock (SYRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mueller Industries Inc. Common Stock vs Spyre Therapeutics Inc. Common Stock — how do they compare? Mueller Industries Inc. Common Stock trades at $60.63 (market cap $13.44B), while Spyre Therapeutics Inc. Common Stock trades at $78.35 (market cap $7.35B). The key difference: Mueller Industries Inc. Common Stock is the larger of the two by market cap, and Mueller Industries Inc. Common Stock pays a 1.15% dividend while Spyre Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mueller Industries Inc. Common Stock for 0 Days and Spyre Therapeutics Inc. Common Stock for 0 Days on average.
| MLI | SYRE | |
|---|---|---|
Market Cap | $13.44B | $7.35B |
Volume | 1,191,194 | 1,624,631 |
Sector | Industrials | Health |
52-Week High | $70.42 | $108.92 |
52-Week Low | $49.29 | $22.18 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $12.05B | $6.35B |
Dividend Yield | 1.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mueller Industries Inc. Common Stock
Mueller Industries, Inc. is a US industrial manufacturer and the only vertically integrated producer of copper tube, fittings, and brass rod and forgings in North America, operating through its Piping Systems, Industrial Metals, and Climate segments.
Read more on MLI →About Spyre Therapeutics Inc. Common Stock
Spyre Therapeutics develops extended half-life antibody therapies for inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Its pipeline targets pathways such as α4β7, TL1A, and IL-23 with antibodies engineered for infrequent subcutaneous dosing and potential combination use.
Read more on SYRE →
